← Leaderboards
Kanecia Zimmerman
Duke University
$1,381,115
Attributed
$1,381,115
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2019–21$2M$1.5M$1M$500K$0
'19
'20
'21
Funding mix
By agency
NIH$1,381,115 · 1
By mechanism
N01$1,381,115 · 1
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Christoph Hornik$12,153,670
- Daniel K Benjamin$109,874,279
- Kanecia Obie Zimmerman$7,696,546
- Kevin M Watt$9,629,862
- Herbert Kim Lyerly$48,598,090
Others in their field
Other Emerging Leaders on “Child”
- April Brinkoetter · Hungry Heart Media, Inc.$57,302,265
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$29,616,650
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$28,898,304
- Ellen Gould Chadwick · Harvard University D/B/A Harvard School Of Public Health$25,473,113
- Beth Baseler · Leidos Biomedical Research, Inc.$22,470,677
- Gaurav J Dave · Duke University$17,082,764
Research focus
ChildPharmaceutical PreparationsSafetyOff-PatentChildhoodDoseEpidemiologic DataAdolescentGrowthDrug IndustryBest Pharmaceuticals For Children ActBiological MarkersAreaDevelopment PlansData AnalysesDrug MetabolismClinical ResearchClinical TrialsBaseCommunitiesCongressesComparativeAcademiaClinically Relevant
Grant awards (4)
BPCA PHARMACOEPIDEMIOLOGY (REAL WORLD DATA) STUDIES$600,000
N01 · FY2021 · HD · contact PI
PTN, PHARMACEUTICALS (PK) AND SAFETY OF COMMONLY USED DRUGS IN LACTATING WOMEN AND BREASTFED INFANTS (CUDDLE 2.0) NETWORK$416,211
N01 · FY2021 · HD · contact PI
BPCA INNOVATIVE TRIAL DESIGNS FOR DOSING, SAFETY, AND EFFICACY IN PEDIATRIC THERAPEUTICS$349,173
N01 · FY2020 · HD · contact PI
BPCA INNOVATIVE TRIAL DESIGNS FOR DOSING, SAFETY, AND EFFICACY IN PEDIATRIC THERAPEUTICS$15,731
N01 · FY2019 · HD · contact PI